Page 1598 - Cote clinical veterinary advisor dogs and cats 4th
P. 1598

804   Polyarthritis


           distal) should arouse suspicion. Confirmation   from nonseptic arthritis (only occasionally   with NSAIDs (e.g., meloxicam 0.1 mg/kg
           rests on arthrocentesis with fluid analysis of mul-  are organisms seen), although the presence   PO q 24h).
  VetBooks.ir  changes. Further testing (tick titers, cultures,   ○   Culture: synovial fluid cultures are often   Chronic Treatment  2
                                                  of degenerate or toxic neutrophils suggests
           tiple joints and radiography to evaluate erosive
                                                  septic arthritis.
                                                                                 •  IMPA: prednisone/prednisolone 1.1 mg/kg
           screening for cancer) is required to identify an
           underlying cause and guide management. Suc-
                                                                                   >  25 kg;  [p.  609]  for  body  surface  area
                                                  70%). When septic arthritis is suspected,
           cessful management requires that any underlying   negative (false-negative rates of 20%-  PO q 12h (20 mg/m  PO q 12h for dogs
           cause be identified and treated. A diagnostic and   consider additional cultures of synovial   conversion) until resolution of signs (usually
           treatment approach is presented on p. 1441.  membrane, blood, and/or urine. Special   2-4 weeks), then slowly reduce the dose and
                                                  media may be required to culture L-form   administer q 48h. Average of 3-6 months
           Differential Diagnosis                 bacteria and Mycoplasma.         but rarely lifelong treatment is required.
           •  Neurologic disease (e.g., spinal cord or brain   •  Titers  and/or  polymerase  chain  reaction   •  If glucocorticoid’s adverse effects are marked
            disorders, neuromuscular diseases)  (PCR):  B. burgdorferi,  E. ewingii,  A.   or high doses are necessary to suppress
           •  Muscular disease (e.g., polymyositis)  phagocytophilum, Bartonella spp, Leishmania  signs, consider other immunosuppressive
           •  Orthopedic  disease  (e.g.,  bilateral  cranial   •  Echocardiogram: suspected bacterial endocar-  drugs such as azathioprine, leflunomide,
            cruciate ligament rupture, degenerative joint   ditis (e.g., heart murmur, especially if recent   cyclosporine, cyclophosphamide, with lower
            disease)                            onset and/or diastolic [p. 294])   dosages of glucocorticoids.
           •  Cardiac disease (e.g., pericardial effusion)  •  Serum antinuclear antibody and rheumatoid   •  Shar-pei fever requires intermittent long-term
           •  Metabolic  disease  (e.g.,  hypoglycemia,   factor: suspected SLE or rheumatoid arthritis,   treatment.
            hypocalcemia)                       respectively; the tests have limited accuracy.  •  Septic arthritis: antibiotics required until 2
           •  Hematologic disease (e.g., acute blood loss)  •  Cerebrospinal fluid tap (pp. 1080 and 1323)   weeks after infection has resolved; often a
                                                if meningitis is suspected         minimum of 6 weeks.
           Initial Database                   •  Thoracic radiographs and abdominal ultra-
           •  Orthopedic  (p.  1143)  and  neurologic  (p.   sound exam to evaluate remote infection,   Nutrition/Diet
            1136) exams to rule out other disorders  GI disease, or neoplasia    Caloric control is necessary to avoid weight gain
           •  CBC, serum biochemistry profile, urinalysis                        by patients receiving glucocorticoids.
            ○   Anemia and leukocytosis are common in    TREATMENT
              idiopathic polyarthritis but are nonspecific.                      Drug Interactions
              Thrombocytopenia may suggest vector-  Treatment Overview           Consult a formulary for possible interactions.
              borne infection.                Treatment depends on cause. Sometimes, despite
            ○   Serum chemistry profile to assess organ   treating the underlying cause, a course of pred-  Possible Complications
              function                        nisone is required to resolve the polyarthritis.   •  Secondary infections from immunosuppres-
            ○   Proteinuria may be indicative of GN   For cases of IMPA, immunosuppressive doses   sive drugs
              (immune mediated) or amyloidosis  of predniso(lo)ne are the treatment of choice,   •  Prednisone has many potential adverse effects.
           •  Radiographs  to  distinguish  erosive  from   and after resolution of clinical signs, usually   •  Azathioprine: myelosuppression, hepatotoxic-
            nonerosive polyarthritis          within 2 weeks, glucocorticoids should be slowly   ity, acute pancreatitis; avoid in cats
            ○   Erosive polyarthritis is characterized by   tapered over 4-6 months. Insufficient dosages   •  Leflunomide: hepatotoxicity, gastrointestinal
              subchondral bone destruction, seen as   and/or administration for insufficient periods   upset, cytopenias
              an irregular joint surface or punched-out   are important causes of treatment failure.
              erosion of bone at the joint space (p. 888).                       Recommended Monitoring
              In advanced cases of joint deformity, loss of   Acute General Treatment  •  Primarily resolution of clinical signs; ideally,
              mineralization of the epiphysis and calcifica-  •  Doxycycline  10 mg/kg  PO  q  24h  for  28   repeat arthrocentesis to see if cell counts have
              tion of soft tissues of the joint may be seen.   days for tick-borne infections, Mycoplasma,   returned to normal.
              Often affects distal joints most severely.  and L-form bacteria    •  Monthly  CBC,  liver  enzymes  for  animals
            ○   Nonerosive polyarthritis has no bony   ○   Instruct clients to administer a bolus of   receiving immunosuppressive drugs.
              abnormalities; signs of joint effusion and   water or morsel of food after each dose
              soft-tissue swelling may be apparent.  to enhance esophageal transit.   PROGNOSIS & OUTCOME
                                              •  Prednisone/prednisolone  1.1 mg/kg  PO
           Advanced or Confirmatory Testing     q 12h initially for nonerosive and erosive   •  Nonerosive IMPA: good to guarded, ≈30%
           •  Arthrocentesis (p. 1059); two or more joints   noninfectious IMPA    of  cases relapse  and  may be  difficult  to
            should be sampled.                •  Cyclosporine  or  leflunomide  are  effective   control or may require lifelong treatment
            ○   The tarsi and carpi are especially useful   alternative treatments for IMPA.  •  Juvenile hereditary arthritis of Akitas: very
              because of frequency of involvement and   •  Broad-spectrum antibiotics (e.g., amoxicillin-  poor; does not respond to immunosuppres-
              ease of access.                   clavulanate 22 mg/kg PO q 12h) or   sive therapy
            ○   Gross appearance: normal synovial fluid is   cephalosporins (e.g., cephalexin 22 mg/kg   •  Calicivirus infection of cats: excellent; gener-
              viscous (tenacious), scant in volume, and   PO q 8h [dogs], 20 mg/kg PO q 12h [cats]   ally resolves in 3 days with supportive care
              clear, whereas synovial  fluid of animals   or cefadroxil 22 mg/kg PO q 12-24h [dogs   •  Noninfectious  erosive  arthritis:  guarded;
              with polyarthritis is generally thin/watery   and cats]) pending cultures in suspected or   arthrodesis or splints may improve quality
              and may be copious (several milliliters)   confirmed cases of septic arthritis  of life
              and potentially turbid (more so with   •  Surgical joint lavage and drainage sometimes   •  Infectious arthritis: provided the arthritis is
              infectious/septic polyarthritis).  are required for septic arthritis.  nonerosive and the infection can be treated,
            ○   Synovial fluid analysis: neutrophils pre-  •  Analgesia may be required, but avoid com-  the prognosis is good.
              dominate in inflammatory polyarthritis   bination of nonsteroidal antiinflammatory
              (distinguishing them from the more   drugs (NSAIDs) and glucocorticoids. Pain    PEARLS & CONSIDERATIONS
              common degenerative arthropathies), and   often resolves quickly with appropriate treat-
              total cell counts are always > 3000/mcL,   ment of IMPA or vector-transmitted disease.   Comments
              often ≥ 40,000/mcL. Cytologic exam is   Shar-pei fever or other arthropathies not   •  Polyarthritis  should  be  suspected  in  any
              seldom  helpful  in  distinguishing  septic   treated with glucocorticoids may be treated   animal that is reluctant to walk or in any

                                                     www.ExpertConsult.com
   1593   1594   1595   1596   1597   1598   1599   1600   1601   1602   1603